Overview

Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in obese or overweight elderly subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Arena Pharmaceuticals
Eisai Inc.